Sunflower Pharmaceuticals Group Co Ltd (002737) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.028x

Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-117.97 Million ≈ $-17.26 Million USD) by net assets (CN¥4.23 Billion ≈ $619.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002737 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Sunflower Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sunflower Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Zhengguang Industrial Co. Ltd. SHE:301092	N/A
Motus Holdings Ltd JSE:MTH	0.273x
U Blox Holding AG SW:UBXN	0.020x
Ina Invest Holding AG SW:INA	0.015x
Bangkok Chain Hospital Public Company Limited BK:BCH-R	0.032x
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	-0.006x
Tianjin Ringpu Bio Tech SHE:300119	0.020x
Bio-Thera Solutions Ltd SHG:688177	-0.324x

Annual Cash Flow Conversion Efficiency for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Sunflower Pharmaceuticals Group Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.99 Billion ≈ $583.96 Million	CN¥574.97 Million ≈ $84.14 Million	0.144x	+315.08%
2024-12-31	CN¥4.59 Billion ≈ $671.66 Million	CN¥-307.48 Million ≈ $-44.99 Million	-0.067x	-136.31%
2023-12-31	CN¥5.00 Billion ≈ $732.34 Million	CN¥923.30 Million ≈ $135.11 Million	0.184x	-58.45%
2022-12-31	CN¥4.44 Billion ≈ $649.53 Million	CN¥1.97 Billion ≈ $288.39 Million	0.444x	+101.93%
2021-12-31	CN¥3.94 Billion ≈ $575.83 Million	CN¥865.23 Million ≈ $126.61 Million	0.220x	-36.27%
2020-12-31	CN¥3.39 Billion ≈ $496.17 Million	CN¥1.17 Billion ≈ $171.19 Million	0.345x	+20.58%
2019-12-31	CN¥3.43 Billion ≈ $501.87 Million	CN¥981.33 Million ≈ $143.60 Million	0.286x	+13.53%
2018-12-31	CN¥3.44 Billion ≈ $502.93 Million	CN¥866.21 Million ≈ $126.75 Million	0.252x	+42.60%
2017-12-31	CN¥3.16 Billion ≈ $462.64 Million	CN¥558.77 Million ≈ $81.77 Million	0.177x	+45.25%
2016-12-31	CN¥2.80 Billion ≈ $410.38 Million	CN¥341.23 Million ≈ $49.93 Million	0.122x	+152.41%
2015-12-31	CN¥2.61 Billion ≈ $381.99 Million	CN¥125.84 Million ≈ $18.41 Million	0.048x	-72.75%
2014-12-31	CN¥2.28 Billion ≈ $333.59 Million	CN¥403.23 Million ≈ $59.00 Million	0.177x	-47.60%
2013-12-31	CN¥869.02 Million ≈ $127.17 Million	CN¥293.34 Million ≈ $42.93 Million	0.338x	-21.79%
2012-12-31	CN¥758.39 Million ≈ $110.98 Million	CN¥327.31 Million ≈ $47.90 Million	0.432x	-8.95%
2011-12-31	CN¥543.47 Million ≈ $79.53 Million	CN¥257.60 Million ≈ $37.70 Million	0.474x	--

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.07 Billion CNY

Market Cap Rank

#8928 Global

#2246 in China

Share Price

CN¥12.10

Change (1 day)

-0.41%

52-Week Range

CN¥11.89 - CN¥16.74

All Time High

CN¥28.79